Next-generation Sequencing Market Worth $14.8 Billion By 2030

Published On: November 21, 2022

The global next-generation sequencing market size totaled a valuation of USD 4.83 billion in 2021. The market growth is anticipated to witness growth at a CAGR of 12.4% from 2022 to 2030. NSG is a technology with scalability with ultrahigh throughput and high speed to determine nucleotides in the genome. The growth of the market is attributed to the rising penetration of genome mapping programs, technological emergence in sequencing platforms, and growing awareness regarding the benefits of NSG solutions.

Growing research activities to develop advanced and efficient NSG systems with reduced costs are fuelling market growth. In personalized medications, the NSG tool identifies the gene expressions and caters to the medications as per the patient characteristics. The development of NSG solutions is estimated to revolutionize the healthcare system during the forecast period, offering a precise diagnosis.

 To request a sample copy or view summary of this report, "please" click the link below:

Next Generation Sequencing Market Report Highlights

• The surge of new products by companies is driving the growth of the genomics segment. Additionally, the presence of companies involving in the provision of the “Personal Genome Service” are contributing to the segment growth

• The sequencing segment accounted for a market share of 54.7% in 2021. The NSG sequencing is the crucial phase of the workflow and accounts for a larger market share

• North America led the next generation sequencing market accounting for over 49.2% of the total market share in 2021. The availability of advanced healthcare infrastructure and growing investments in R&D activities is creating opportunities for the market to exhibit growth in the region

• The market in the Asia Pacific is anticipated to gain traction during the forecast period. Rising technological integration of the NSG methodologies and growing focus on the development of the healthcare system are aggrandizing market expansion in the region

• Increasing demand for NSG solutions is creating a competitive edge among the market players. Key players are adopting strategies such as mergers & acquisitions, collaborations, and geographical expansion 

Next-Generation Sequencing Market Segments

Next-generation Sequencing Technology Outlook (Revenue, USD Million, 2018 - 2030)
    • WGS
    • Whole Exome Sequencing
    • Targeted Sequencing & Resequencing
        • DNA-based
        • RNA-based

Next-generation Sequencing Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Platforms
        • Sequencing
        • Data Analysis
    • Consumables
        • Sample preparation
        • Target Enrichment
        • Others

Next-generation Sequencing Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Oncology
        • Diagnostics and Screening
            • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
            • Companion Diagnostics
            • Other Diagnostics
        • Research Studies
    • Clinical Investigation
        • Infectious Diseases
        • Inherited Diseases
        • Idiopathic Diseases
        • Non-communicable/Other Diseases
    • Reproductive Health
        • NIPT
            • Aneuploidy
            • Microdeletions
        • PGT
        • Newborn Genetic Screening
        • Single Gene Analysis
    • HLA Typing/Immune System Monitoring
    • Metagenomics, Epidemiology & Drug Development
    • Agrigenomics & Forensics
    • Consumer Genomics

Next-generation Sequencing Workflow Outlook (Revenue, USD Million, 2018 - 2030)
    • Pre-sequencing
        • NGS Library Preparation Kits
        • Semi-automated Library Preparation
        • Automated Library Preparation
        • Clonal Amplification
    • Sequencing
    • NGS Data Analysis
        • NGS Primary Data Analysis
        • NGS Secondary Data Analysis
        • NGS Tertiary Data Analysis

Next-generation Sequencing End-use Outlook (Revenue, USD Million, 2018 - 2030)
    • Academic Research
    • Clinical Research
    • Hospitals & Clinics
    • Pharma & Biotech Entities
    • Other Users

Next-generation Sequencing Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
        • U.S.
        • Canada
    • Europe
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
    • Asia Pacific
        • Japan
        • China
        • India
        • South Korea
        • Australia
    • Latin America
        • Brazil
        • Mexico
    • Middle East & Africa
        • South Africa
        • Saudi Arabia

List of key players of the Next-Generation Sequencing Market
    • llumina
    • F. Hoffman-La Roche Ltd.
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Oxford Nanopore Technologies
    • PierianDx
    • Genomatix GmbH
    • DNASTAR, Inc.
    • Perkin Elmer, Inc.
    • Eurofins GATC Biotech GmbH
    • BGI